Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Eleven Biotherapeutics, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 0.8679||$ 13.775|
|Low||$ 0.7501||$ 0.2511|
The current last sale of $0.78 is 210.63% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a preclinical stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that we apply to the discovery and development of protein therapeutics to treat diseases of the eye. Our therapeutic approach is based on the role of cytokines in diseases of the eye, our understanding of the structural biology of cytokines and our ability to rationally design and engineer proteins to modulate the effects of cytokines. Cytokines are cell signaling molecules found in the body that can have important inflammatory effects. Our most advanced product candidate, which is still in preclinical development, is EBI-031, which we designed, engineered and generated using our AMP-Rx platform and are developing as an intravitreal injection for diabetic macular edema, or DME, and uveitis. ... More ...
Where does EBIO fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$|
|Quarterly EPS Est:|